Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Revenue (2016 - 2025)

Historic Revenue for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $283.4 million.

  • Prestige Consumer Healthcare's Revenue fell 236.74% to $283.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year decrease of 130.82%. This contributed to the annual value of $1.1 billion for FY2025, which is 110.23% up from last year.
  • Prestige Consumer Healthcare's Revenue amounted to $283.4 million in Q4 2025, which was down 236.74% from $274.1 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Revenue's 5-year high stood at $296.5 million during Q1 2025, with a 5-year trough of $237.8 million in Q1 2021.
  • For the 5-year period, Prestige Consumer Healthcare's Revenue averaged around $276.1 million, with its median value being $277.0 million (2022).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Revenue skyrocketed by 1734.44% in 2021, and later tumbled by 659.27% in 2025.
  • Prestige Consumer Healthcare's Revenue (Quarter) stood at $274.5 million in 2021, then increased by 0.38% to $275.5 million in 2022, then rose by 2.62% to $282.7 million in 2023, then increased by 2.68% to $290.3 million in 2024, then dropped by 2.37% to $283.4 million in 2025.
  • Its last three reported values are $283.4 million in Q4 2025, $274.1 million for Q3 2025, and $249.5 million during Q2 2025.